Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  Antibodies
  Mutations
  AlzGene
  Research Models
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Expert Opinion
  Ask the Expert
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Genes: AlzGene
 Overview of concordant linkage/association regions observed in full
 genome screens published until June 1, 2007.
Back Search Methods Disclaimer Credits
Chromosome Linkage-Studies Association-Studies
 

Pericak-Vance
[1997]a

Pericak-Vance
[2000]a

Curtis
[2001]a

Olson
[2002]a

Myers
[2002]a

Li
[2002]a,b

Blacker
[2003]a

Scott
[2003]a

Holmans
[2005]a

Sillen
[2005]

Gordon
[2006]a

Lee
[2006]

Zubenko
[1998]

Hiltunen
[2001]

Farrer
[2003]

1p36 - -     1.7 - - - 3.8 - - - - P=0.006 -
   q23-31 - - - - - - 2.1 - - - - - P=0.003 - -
2p23-24 - - - - - - - - - - - 2.9 - P=0.009 P=0.005
   p12-q11 - - - - - - - - - - P<0.001 - - - -
   q34 - - - - - - - 3.2 - - - 2.8 - - -
4p16 - - - - - - - - - - P=0.002 1.6 - - -
   q35 - -     - 2.3 1.8 - - - - - - - -
5p13-15 - 2.2 1.6 2.0 2.8 - 1.4 - - - - 1.9 - P=0.001 -
6p21
   q15-16
   q25-27
-
>1.5
-
-
-
-
-
1.6
-
-
-
3.9
-
1.9
-
-
-
-
1.9
-
2.2
-
-
-
2.4
-
-
- - 2.2
-
-
-
-
-
P=0.003
-
-
-
-
-
9p21
   q22-34
-
-
4.3
2.0
1.4
1.6
-
2.6
1.8
1.8
-
-
-
2.9
4.6
-
-
4.2
- - -
1.9
-
-
-
-
P<0.001
-
10q21-22
   q25-26
-
-
-
-
2.0
-
2.1
-
4.1
-
-
2.4
1.8
1.9
-
-
4.1
-
- - -
2.5
-
-
-
-
P=0.001
-
12p11-13 3.9 - 2.1 - 1.4 - - - 3.3 - - - - - -
14q22 - - - - - - 2.2 - - - - 2.0 - - -
19q13 - 3.6 1.9 3.1 1.6 3.3 7.7 - 2.3 4.8 - - P<0.001 - -
21q21-22 - - - 5.9 1.6 - 2.5 - 4.0 - - - - - -
Xp11-21 - - - - 1.6 -
1.6 - - - - - - - -

Only two-sided P-value ≤ 0.01 (ie. LOD scores ≥ 1.4) with markers no more than 25 MB apart in at least two studies were considered. Numbers assigned to linkage studies represent LOD scores. Note that the results by Kehoe et al. (1999) and Lee et al (2004) were not considered here as they were significantly extended in the same groups’ follow-up genome screen (Myers et al. [2002]) and Lee et al [2006], respectively). Only whole-genome studies assessing linkage/association with AD risk, onset age or rate of progression are included. Note that additional studies have been published that performed re-analyses of existing data either by incorporating other variables (such as evidence for AD with and without psychosis [e.g. Bacanu et al, 2002, Avramopoulos et al, 2005, Hollingworth et al, 2007, or parent of origin effects [e.g. Basset et al, 2002].

a Analyses of these studies are conducted on samples that show partial or complete overlap; these samples include AD families from the Duke Center of Human Genetics (CHG), Joseph and Kathleen Bryan Alzheimer’s Disease Research Center (Bryan ADRC), Indiana Alzheimer’s Disease Research Center National Cell Repository (IADRC), National Institute of Mental Health (NIMH), Vanderbilt University, and University of California Los Angeles (UCLA). Note that each study used distinct marker sets and/or analyses strategies so that none of the entries above actually represent duplicate results; not all of the overlapping samples were used in each study.

b Only findings of AD sample are considered here.

Please also see disclaimer for more information on this genome screen overview.


References

Avramopoulos, D., M. D. Fallin, et al. (2005). "Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms." Am J Med Genet B Neuropsychiatr Genet 132(1): 9-13. Abstract

Bacanu, S. A., B. Devlin, et al. (2002). "Linkage analysis of Alzheimer disease with psychosis." Neurology 59(1): 118-20. Abstract

Bassett, S. S., D. Avramopoulos, et al. (2002). "Evidence for parent of origin effect in late-onset Alzheimer disease." Am J Med Genet 114(6): 679-86. Abstract

Blacker, D., L. Bertram, et al. (2003). "Results of a high-resolution genome screen of 437 Alzheimer's disease families." Hum Mol Genet 12(1): 23-32. Abstract

Curtis, D., B. V. North, et al. (2001). "A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer's disease." Ann Hum Genet 65(Pt 5): 473-81. Abstract

Farrer, L. A., A. Bowirrat, et al. (2003). "Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community." Hum Mol Genet 12(4): 415-22. Abstract

Gordon, D., C. Haynes, et al. (2006). "Increase in Linkage Information by Stratification of Pedigree Data into Gold-Standard and Standard Diagnoses: Application to the NIMH Alzheimer Disease Genetics Initiative Dataset." Hum Hered 61(2): 97-103. Abstract

Hiltunen, M., A. Mannermaa, et al. (2001). "Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland." Neurology 57(9): 1663-8. Abstract

Hollingworth P., M.L. Hamshere, et al. (2007) "Increased familial risk and genomewide significant linkage for Alzheimer's disease with psychosis." Am J Med Genet B Neuropsychiatr Genet. 2007 May 10; [Epub ahead of print] Abstract

Holmans, P., M. Hamshere, et al. (2005). "Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease." Am J Med Genet B Neuropsychiatr Genet 135(1): 24-32. Abstract

Lee, J. H., R. Cheng, et al. (2006). "Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease." Arch Neurol 63(11): 1591-8. Abstract

Lee, J. H., R. Mayeux, et al. (2004). "Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics." Mol Psychiatry 9(11): 1042-51. Abstract

Li, Y. J., W. K. Scott, et al. (2002). "Age at onset in two common neurodegenerative diseases is genetically controlled." Am J Hum Genet 70(4): 985-93. Abstract

Myers, A., F. Wavrant De-Vrieze, et al. (2002). "Full genome screen for Alzheimer disease: Stage II analysis." Am J Med Genet 114(2): 235-44. Abstract

Olson, J. M., K. A. Goddard, et al. (2002). "A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region." Am J Hum Genet 71(1): 154-61. Abstract

Pericak-Vance, M. A., M. P. Bass, et al. (1997). "Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12." Jama 278(15): 1237-41. Abstract

Pericak-Vance, M. A., J. Grubber, et al. (2000). "Identification of novel genes in late-onset Alzheimer's disease." Exp Gerontol 35(9-10): 1343-52. Abstract

Scott, W. K., E. R. Hauser, et al. (2003). "Ordered-subsets linkage analysis detects novel Alzheimer disease Loci on chromosomes 2q34 and 15q22." Am J Hum Genet 73(6): 1041-51. Abstract

Sillen, A., C. Forsell, et al. (2006). "Genome scan on Swedish Alzheimer's disease families." Mol Psychiatry 11(2): 182-6. Abstract

Zubenko, G. S., H. B. Hughes, et al. (1998). "A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution." Genomics 50(2): 121-8. Abstract

Copyright © 1996-2008 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad